G
LIVE

Serial Number

99399481

Owner

Genetix Biotherapeutics Inc.

Attorney

Christopher K. Albert

Filing Date

Sep 18, 2025

Add to watchlist:

No watchlists yet
View on USPTO

G Trademark

Serial Number: 99399481

G is a trademark filed by Genetix Biotherapeutics Inc. on September 18, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Genetix Biotherapeutics Inc. (63 trademarks)

455 Grand Union Boulevard
Somerville, MA 02145

Entity Type: 03

GENETIX BIOTHERAPEUTICS INC.

455 GRAND UNION BOULEVARD
SOMERVILLE, MA 02145

Entity Type: 03

Trademark Details

Filing Date

September 18, 2025

Registration Date

Not Registered

Published for Opposition

April 7, 2026

Goods & Services

Providing educational information relating to insurance and financing for gene therapy; Providing educational information via the internet relating to insurance and financing for gene therapy; Providing a web site featuring educational information relating to insurance and financing for gene therapy

Referrals in the field of gene therapy, namely, providing an internet website for connecting medical patients and physicians with qualified treatment centers for gene therapy; Promoting public awareness of gene therapy

Pharmaceutical research and development; Research and development in the field of genetic diseases and gene therapies; Providing online non-downloadable software for documenting data on the source, manufacturer, packaging, storage, transport, and delivery of materials for use in therapies and therapeutics

Pharmaceutical preparations and substances for the treatment of genetic diseases; Pharmaceutical preparations for the treatment of blood diseases; Pharmaceutical preparations and substances for the treatment of genetic diseases and disorders

Providing medical information in the field of genetic diseases and gene therapies; Providing a website featuring medical information in the field of genetic diseases and gene therapies; Medical information services provided via the internet; Providing educational information relating to genetic diseases and treatment for genetic diseases; Providing educational information via the internet relating to genetic diseases and treatment for genetic diseases; Providing a website that features educational information relating to genetic diseases and treatment for genetic diseases

Arranging and conducting of conferences, seminars, symposiums, classes, workshops, presentations, seminars, and in-person educational forums in the field of gene therapy; Providing prerecorded audio, visual, and audio-visual educational programs, not downloadable, via video-on-demand services, that relate to gene therapy

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 2, 2026 NOAM
POST PUBLICATION AMENDMENT - ENTERED
May 18, 2026 CHPB
ASSIGNED TO PETITION STAFF
May 14, 2026 APET
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 7, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 7, 2026 PUBO
ASSIGNED TO LIE
Apr 6, 2026 ALIE
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 1, 2026 NONP
TEAS POST PUBLICATION AMENDMENT RECEIVED
Mar 28, 2026 EPPA
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 13, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 7, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 7, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 7, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 13, 2026 GNRN
NON-FINAL ACTION E-MAILED
Feb 13, 2026 GNRT
NON-FINAL ACTION WRITTEN
Feb 13, 2026 CNRT
ASSIGNED TO EXAMINER
Feb 11, 2026 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 10, 2026 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 10, 2026 NWOS
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 30, 2025 ASGN
APPLICATION FILING RECEIPT MAILED
Sep 18, 2025 MAFR
NEW APPLICATION ENTERED
Sep 18, 2025 NWAP